Reports
Reports
Gauge Marketability Across Various Therapeutic Areas
Total Reports: 409
The global radiodermatitis market is witnessing steadiness due to increasing prevalence of cancer and rising adoption of radiation therapy treatments worldwide. Rising awareness regarding radiation induced skin damage among healthcare professionals notably supports demand for therapeutic and preventive skincare solutions. The development of new topical products, barrier films, and advanced
Rep Id : TMRGL2157 | Published | Pharmaceutical | May 2026
The anti-inflammatory therapeutics market is witnessing steadiness due to increasing prevalence of chronic diseases, rising aging population, and continuous innovation in biologics therapies development. The market demonstrates a strong potential for growth due to rising healthcare expenditures, improved diagnostic understanding, and increasing use of targeted medical therapies in the major
Rep Id : TMRGL1907 | Published | Pharmaceutical | May 2026
The chemotherapy-induced nausea and vomiting existing and pipeline drugs market is evolving from mere symptom control toward guideline-driven, optimized, and supportive oncology care. While CINV cannot be categorized as a life-threatening condition, its impact on patient quality, treatment adherence, and chemotherapy completion rates does make it clinically critical. Market growth
Rep Id : TMRGL776 | Published | Pharmaceutical | May 2026
The global Foot-and-Mouth Disease (FMD) vaccine market shows ongoing expansion as there is growing demand to safeguard animal health and maintain food supply security. The two factors of rising livestock numbers and the regular occurrence of FMD outbreaks in Asia Africa and Latin America have created a greater need for
Rep Id : TMRGL2480 | Published | Pharmaceutical | April 2026
The high potency active pharmaceutical ingredients (HPAPI) market has a promising future with significant growth potential. This potential is mainly driven by the growing requirement for targeted therapies that are mostly based on oncology but also focused on chronic diseases. Personalized medicine is the main reason behind the increased demand
Rep Id : TMRGL748 | Published | Pharmaceutical | March 2026
The major driving forces for the growth of the osteoporosis drug market include the exploding aging population worldwide and the increased incidences of osteoporosis among post-menopausal women and the aged population. In addition, the raised awareness of the importance of bone health, early detection of the condition with the help
Rep Id : TMRGL133 | Published | Pharmaceutical | February 2026
The anti-venom market is expanding owing to a series of epidemiological, healthcare-related, and governmental factors. The increasing cases of snake bites and scorpion stings within tropical and subtropical areas of the world, as a result of population growth and climate change, have led to a greater demand for treatment solutions
Rep Id : TMRGL35540 | Published | Pharmaceutical | January 2026
The primary drivers to the expanding psychotropic drugs market include the rising prevalence of mental disorders such as depression, schizophrenia, anxiety, bipolar disorders, ADHD, and the other mental disorders. In addition, the awareness about mental disorders has reduced the stigma related to mental illnesses.
Rep Id : TMRGL79453 | Published | Pharmaceutical | January 2026
The factors resulting in the development of hypertrophic cardiomyopathy (HCM) therapeutics market include the awareness of the disease and its diagnosis, together with technological improvements in cardiac imaging, facilitating diagnosis of the disease at an early stage and with higher accuracy.
Rep Id : TMRGL7553 | Published | Pharmaceutical | January 2026
Increased use of companion diagnostics and robust development of biomarker testing lead to better patient stratification, which, in turn, implies that a greater number of targeted therapies are utilized.
Rep Id : TMRGL504 | Published | Pharmaceutical | January 2026
Several factors are driving the growth of the opioid-induced constipation treatment market for both - clinical and outpatient settings.
Rep Id : TMRGL6862 | Published | Pharmaceutical | January 2026
Regulatory harmonization and reimbursement-friendly policies drive the market growth, facilitating access by more patients and inclusion of formularies.
Rep Id : TMRGL86927 | Published | Pharmaceutical | January 2026
Improved insurance coverage and increasing healthcare expenditure have expanded access to therapies and propelled affordability, thus driving growth of the asthma and COPD drugs market.
Rep Id : TMRGL86923 | Published | Pharmaceutical | January 2026
India animal healthcare sector has seen robust expansion, driven by a rising awareness of animal health and increasing disposable incomes.
Rep Id : TMRGL23048 | Published | Pharmaceutical | December 2025
Adoption of intraoperative radiation therapy is driven by growing demand for single-session treatments, short hospitalization, and quick recovery, which is in congruence with value-based care models.
Rep Id : TMRGL74059 | Published | Pharmaceutical | December 2025
GLP-1 analogues market is driven by strong clinical evidence demonstrating benefits to the cardiovascular and metabolic systems, growing healthcare spending, and extended reimbursement plans that further enhance patient access.
Rep Id : TMRGL86893 | Published | Pharmaceutical | December 2025
The non-cystic fibrosis bronchiectasis treatment market is witnessing vigorous expansion owing to multiple compelling drivers.
Rep Id : TMRGL86850 | Published | Pharmaceutical | November 2025
The global kidney cancer drugs market is expected to go steady due to the continuous development in targeted therapies and immuno-oncology, increasing aging population, and wider access to diagnostic testing, which make it possible to give the patients earlier and more personalized treatment.
Rep Id : TMRGL537 | Published | Pharmaceutical | November 2025
Increased diagnostic accuracy and wider availability of high-end ocular imaging are significant drivers to the uveal melanoma treatment market.
Rep Id : TMRGL86847 | Published | Pharmaceutical | November 2025
The key factors driving the growth of sarcopenia treatment market are the aging global population, raised awareness of and diagnosis of sarcopenia, the ongoing influx of nutritional supplementation into mainstream, and the emergence of pharmacological therapies such as myostatin inhibitors and SARMs.
Rep Id : TMRGL28547 | Published | Pharmaceutical | November 2025
Multiple key factors drive the expansion of the Barth syndrome therapeutics market.
Rep Id : TMRGL86829 | Published | Pharmaceutical | November 2025
A number of driving forces fuel acromegaly treatment market growth.
Rep Id : TMRGL86824 | Published | Pharmaceutical | November 2025
The global market for controlled drugs steadily expands with the main driver being the escalating cases of chronic pain, neurological disorders, and psychiatric conditions that need medications that are regulated by the authorities.
Rep Id : TMRGL25964 | Published | Pharmaceutical | November 2025
The abortion drugs market grows at the convergence of clinical practice, regulatory diligence, and shifting distribution models.
Rep Id : TMRGL86809 | Published | Pharmaceutical | November 2025
The synthetic cannabinoids market is undergoing acceleration towing to the increased use of cannabinoids-based drugs in various therapies.
Rep Id : TMRGL74674 | Published | Pharmaceutical | October 2025
The monogenetic disease therapy market is witnessing transformative developments due to extensive research being conducted regarding gene-based treatments transitions medicine into a new frontier of therapeutic choices.
Rep Id : TMRGL86769 | Published | Pharmaceutical | October 2025
The anti-infective drug market is witnessing an upward trajectory as scientific technology advancements toward the development of therapeutic agents become more universally accepted.
Rep Id : TMRGL41204 | Published | Pharmaceutical | September 2025
The global erectile dysfunction medicines market is experiencing consistency, buoyed by rising incidences of lifestyle disorders including diabetes, hypertension, obesity, and cardiovascular ailments-prime causes of erectile dysfunction.
Rep Id : TMRGL1550 | Published | Pharmaceutical | August 2025
The ophthalmic drug market is currently witnessing robust growth because of increased prevalence of eye diseases, advancements in pharmaceutical technology, and enhanced global awareness of the importance of eye care. One of the major reasons for this market expansion is rise in the prevalence of eye disorders.
Rep Id : TMRGL1769 | Published | Pharmaceutical | July 2025
The pain management therapeutics market is poised for steady growth, owing to increasing prevalence of chronic pain conditions including arthritis, neuropathic pain, and pain related to cancer – particularly in aging population. North America has the most advanced market due to it being home to established healthcare delivery systems and
Rep Id : TMRGL1059 | Published | Pharmaceutical | July 2025
Most comprehensive coverage 100+ countries, 2 million+ data points
Personalized pre-sales, on-boarding, and post-sales support
Less assumption, more science - a research methodology perfected through years of rigorous diligence
True to its name, transparency in every minute details from research processes to financials
20% of Fortune 500 are our clients have worked with over 3000 SMEs
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
